Merger Remedies with Chinese Characteristics
Sandra Chan and Joanna Tsai entitled “Merger Remedies with Chinese Characteristics” which appeared in the August 2013 issue of CPI Antitrust Chronicle. The...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Sandra Chan is a Principal in the Competition Practice of Charles River Associates. She has over 15 years of experience in the economics of antitrust liability, damages, and mergers.
Ms. Chan specializes in health care, including competition between hospitals, physician groups, health insurance companies, and pharmaceutical companies. She routinely works with health care claims data (e.g., data from health plans, hospitals, PBMs, etc.) and government health care data (e.g., state discharge data, state all-payers claims data, and Centers for Medicare & Medicaid Services data, etc.) She also has experience in a broad range of other industries, including retail, manufacturing, and technology.
Ms. Chan typically acts as a project manager on the behalf of economic expert witnesses in competition and antitrust matters alleging monopolization, price fixing, and fraud. In addition, she has designed and managed economic analyses of the competitive effects of mergers, including hospitals, manufacturing companies, and retail companies. She has extensive experience analyzing large, complex data and has performed econometric analyses in a number of these antitrust matters. Ms. Chan also has designed damage models for alleged price fixing, attempt to monopolize, and fraud cases.